Cargando…

Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature

The aim of this appraisal of the literature is to elucidate the effects of immunosuppressive and immunomodulating agents used to treat atopic dermatitis (AD) on risk factors for fertility, pregnancy, and breastfeeding. Negative side effects of the psychological and physical stresses associated to AD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heilskov, Sofine, Deleuran, Mette S., Vestergaard, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649192/ https://www.ncbi.nlm.nih.gov/pubmed/33140290 http://dx.doi.org/10.1007/s13555-020-00457-w

Ejemplares similares

Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort
por: Elsgaard, Stine, et al.
Publicado: (2021)

Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results
por: Nygaard, Uffe, et al.
Publicado: (2016)

The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022)

The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis
por: ELSNER, Julie Sophie Hohwü, et al.
Publicado: (2020)

Difficult to control atopic dermatitis
por: Darsow, Ulf, et al.
Publicado: (2013)

Atopic dermatitis and risk of atrial fibrillation or flutter: A 35-year follow-up study
por: Schmidt, Sigrun A.J., et al.
Publicado: (2020)

Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study
por: Riis, Jette Lindorff, et al.
Publicado: (2016)

Memory Buttons in Combination with Mobile Application-Induced Objective and Subjective Effects in Patients with Atopic Dermatitis
por: Joergensen, Kristina M., et al.
Publicado: (2020)

Nomenclature and clinical phenotypes of atopic dermatitis
por: Girolomoni, Giampiero, et al.
Publicado: (2021)

Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry
por: LARSEN, Henrik H. P., et al.
Publicado: (2022)

Association Between Atopic Dermatitis and Educational Attainment in Denmark
por: Schmidt, Sigrun Alba Johannesdottir, et al.
Publicado: (2021)

Disease Mechanisms in Atopic Dermatitis: A Review of Aetiological Factors
por: THYSSEN, Jacob P., et al.
Publicado: (2020)

Melatonin as an Antioxidant and Immunomodulator in Atopic Dermatitis—A New Look on an Old Story: A Review
por: Jaworek, Andrzej Kazimierz, et al.
Publicado: (2021)

Therapeutic Effects and Immunomodulation of Suanbo Mineral Water Therapy in a Murine Model of Atopic Dermatitis
por: Choi, Yoon Jung, et al.
Publicado: (2013)

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
por: DELEURAN, Mette, et al.
Publicado: (2021)

Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
por: Griffiths, Christopher, et al.
Publicado: (2021)

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients
por: Roekevisch, E., et al.
Publicado: (2020)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

Clinical Management of Atopic Dermatitis in Adults: Mapping of Expert Opinion in 4 Nordic Countries using a Modified Delphi Process
por: THYSSEN, Jacob P., et al.
Publicado: (2020)

The Treat-to-Target Project in Atopic Dermatitis: One Year On
por: DE BRUIN-WELLER, Marjolein, et al.
Publicado: (2023)

Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council
por: Eichenfield, Lawrence F., et al.
Publicado: (2021)

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment
por: Bakker, Daphne S., et al.
Publicado: (2019)

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
por: Lobo, Yolanka, et al.
Publicado: (2021)

Complementary and Integrative Therapies for Childhood Atopic Dermatitis
por: Adler-Neal, Adrienne L., et al.
Publicado: (2019)

Current and Emerging Therapies in Pediatric Atopic Dermatitis
por: Johnson, Hadley, et al.
Publicado: (2022)

Current and Emerging Therapies for Atopic Dermatitis in the Elderly
por: Teng, Yan, et al.
Publicado: (2023)

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019)

Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?
por: Hurault, G., et al.
Publicado: (2022)

Atopic dermatitis in adolescence
por: Ricci, Giampaolo, et al.
Publicado: (2011)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Microbiome in atopic dermatitis
por: Wollina, Uwe
Publicado: (2017)

The exposome in atopic dermatitis
por: Stefanovic, Nicholas, et al.
Publicado: (2019)

Cyclosporine and Extracorporeal Photopheresis are Equipotent in Treating Severe Atopic Dermatitis: A Randomized Cross-Over Study Comparing Two Efficient Treatment Modalities
por: Koppelhus, Uffe, et al.
Publicado: (2014)

Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types
por: Bosma, Angela L., et al.
Publicado: (2022)

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015)

Atopic dermatitis and atopic march: which link?
por: Maiello, Nunzia, et al.
Publicado: (2021)

Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies
por: DE BRUIN-WELLER, Marjolein, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i7ic5rtmaueot2hl04qkjllrsd